Featured
AUDIO: What COA said about the application in 2019 to FDA for clinical trials of COA 72 as an anti-HIV drug
Graphic.com.gh
1 minute read
When the Parliamentary Select Committee on Health visited and what COA said about the application in 2019 to FDA for clinical trials of COA 72 as an anti-HIV drug in 2019 and the payment of $5000 registration.
Dr Caleb Mawuli Agbale, the Product Manager briefed the committee members on the operations of COA and the product.